192 related articles for article (PubMed ID: 9829755)
1. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Jacobson HI; Bennett JA; Mizejewski GJ
Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
[TBL] [Abstract][Full Text] [Related]
3. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
4. [Effect of alpha-fetoprotein on the growth of human hepatoma cells in vitro].
Wang XW; Xie H
Shi Yan Sheng Wu Xue Bao; 1999 Mar; 32(1):15-22. PubMed ID: 12548790
[TBL] [Abstract][Full Text] [Related]
5. AFPep: an anti-breast cancer peptide that is orally active.
Bennett JA; DeFreest L; Anaka I; Saadati H; Balulad S; Jacobson HI; Andersen TT
Breast Cancer Res Treat; 2006 Jul; 98(2):133-41. PubMed ID: 16538538
[TBL] [Abstract][Full Text] [Related]
6. Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.
Curran EM; Judy BM; Duru NA; Wang HQ; Vergara LA; Lubahn DB; Estes DM
Clin Cancer Res; 2006 Oct; 12(19):5641-7. PubMed ID: 17000652
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
8. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
9. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
10. A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy.
Jacobson HI; Lemanski N; Agarwal A; Narendran A; Turner KE; Bennett JA; Andersen TT
Cancer Prev Res (Phila); 2010 Feb; 3(2):212-20. PubMed ID: 19934340
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibitory effects of pMC540 and merodantoin on established MCF-7 human breast tumor xenografts.
Sharma R; Gulliya KS
In Vivo; 1995; 9(2):103-8. PubMed ID: 7548784
[TBL] [Abstract][Full Text] [Related]
13. A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture.
Sierralta WD; Epuñan MJ; Reyes JM; Valladares LE; Andersen TT; Bennett JA; Jacobson HI; Pino AM
Oncol Rep; 2008 Jan; 19(1):229-35. PubMed ID: 18097600
[TBL] [Abstract][Full Text] [Related]
14. Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts.
Salcedo R; Martins-Green M; Gertz B; Oppenheim JJ; Murphy WJ
Clin Cancer Res; 2002 Aug; 8(8):2655-65. PubMed ID: 12171898
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30.
Lee-Huang S; Huang PL; Sun Y; Chen HC; Kung HF; Huang PL; Murphy WJ
Anticancer Res; 2000; 20(2A):653-9. PubMed ID: 10810336
[TBL] [Abstract][Full Text] [Related]
16. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
[TBL] [Abstract][Full Text] [Related]
18. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
19. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA
Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of alpha-fetoprotein antisense oligodeoxy-nucleotides and 5-fluorouracil on human hepatoma cell growth.
Wang X; Zhang R; Xie H
Chin Med J (Engl); 1999 Aug; 112(8):743-6. PubMed ID: 11601286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]